EGM
FLXN

Engineers Gate Manager’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Engineers Gate Manager’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-32,774
Closed -$200K – 2402
2021
Q3 		$200K Buy
32,774
+17,874
+120% +$111K 0.01% 1438
2021
Q2 		$123K Buy
14,900
+1,300
+10% +$11.1K 0.01% 1476
2021
Q1 		$122K Buy
+13,600
New +$156K 0.01% 1682

Engineers Gate Manager's FLXN Position: Q4 2021 in Review

Engineers Gate Manager sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 32,774 shares — an estimated $200K sold.

Engineers Gate Manager first reported a position in FLXN in Q1 2021 and held it in 3 quarters. The position peaked at $200K in Q3 2021. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

  • Engineers Gate Manager reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
  • Engineers Gate Manager sold 32,774 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $200K.
  • Engineers Gate Manager first reported a position in Flexion Therapeutics, Inc. in Q1 2021 and held it in 3 quarters.
  • Engineers Gate Manager's Flexion Therapeutics, Inc. position peaked at $200K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on Engineers Gate Manager's 13F filing for Q4 2021, filed 14 Feb 2022.